STERLINBIO

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned ED attaches assets worth over Rs 9,000 cr in Sterling Biotech PMLA case. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sterling Biotech Limited has submitted their response.

The Exchange has sought clarification from Sterling Biotech Limited with respect to news item captioned ��ED attaches assets worth over Rs 9,000 cr in Sterling Biotech PMLA case��. The response from the Company is awaited.

The Exchange has sought clarification from the Company with respect to news item captioned- titled "RBI found irregularities in guarantees to Sterling Bio". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company was aware of any information that has not been announced to the Exch

��The Exchange had sought clarification from the Company with respect to news item captioned- "Sterling Biotech case: Termed proceeds of money laundering Rs 4,701 cr assets attached ". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has no

The Exchange has sought clarification from the Company with respect to news item captioned- "Sterling Biotech case: Termed proceeds of money laundering Rs 4,701 cr assets attached ". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not

STERLINBIO:The Exchange had sought clarification from Sterling Biotech Limited with respect to announcement dated 02-Nov-2018, regarding " Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.".On basis of above the Company is required to clarify following:1. Any other material information not involving commercial secrets<br>2. Salient features, not involving commercial secrets, of the resolution plan approved by the Tribunal, in such form as may be specified<br>3. Approval of res

STERLINBIO:The Exchange has sought clarification from Sterling Biotech Limited with respect to announcement dated 02-Nov-2018, regarding " Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.". On basis of above the Company is required to clarify following: 1. Any other material information not involving commercial secrets<br> 2. Salient features, not involving commercial secrets, of the resolution plan approved by the Tribunal, in such form as may be specified<br> 3. Approval o

The Exchange had sought clarification from the Company with respect to news item captioned- " Delhi Court issues notices to Sterling Biotech owners in Rs 8,100 cr loan fraud case". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not be

STERLINBIO:The Exchange had sought clarification from Sterling Biotech Limited with respect to announcement dated 26-Oct-2018, regarding " Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.".On basis of above the Company is required to clarify following:1. Quantum of claims, if any<br>2. Expected financial implications, if any, due to compensation, penalty etc;<br>3. Brief details of litigation viz. name(s) of the opposing party, court/ tribunal/agency where litigation is filed

STERLINBIO:The Exchange has sought clarification from Sterling Biotech Limited with respect to announcement dated 26-Oct-2018, regarding " Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.". On basis of above the Company is required to clarify following: 1. Quantum of claims, if any<br> 2. Expected financial implications, if any, due to compensation, penalty etc;<br> 3. Brief details of litigation viz. name(s) of the opposing party, court/ tribunal/agency where litigation is

The Exchange has sought clarification from the Company with respect to news item captioned- " Delhi Court issues notices to Sterling Biotech owners in Rs 8,100 cr loan fraud case". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not be

The Exchange has sought clarification from the Company with respect to news item captioned- " ED to seek fugitive economic offender tag for 4 accused in Sterling Biotech case". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been a

The Exchange had sought clarification from the Company with respect to news item captioned- " ED files chargesheet against 191 entities ". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announced to the Exchanges under Regula

The Exchange has sought clarification from the Company with respect to news item captioned- " ED files chargesheet against 191 entities ". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announced to the Exchanges under Regula

The Exchange had sought clarification from the Company with respect to news item captioned- Promoters of Vadodara based Sterling Biotech offered Rs.3000 crores as settlement to consortium of banks against Rs.5400 crores bank loan scam.The response from the Company is attached.

The Exchange had sought clarification from the Company with respect to news item captioned- Bank loan fraud: ED to file charge sheet against Sterling Biotech promoters. The response from the Company is attached.

The Exchange has sought clarification from the Company with respect to news item captioned- Promoters of Vadodara based Sterling Biotech offered Rs.3000 crores as settlement to consortium of banks against Rs.5400 crores bank loan scam.In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of

The Exchange has sought clarification from the Company with respect to news item captioned- Bank loan fraud: ED to file charge sheet against Sterling Biotech promoters. In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any in

The Exchange had sought clarification from the Company with respect to news item captioned- Rs 50-bn scam: Sterling Biotech director Nitin Sandesara held in Dubai. The response from the Company is attached

The Exchange has sought clarification from the Company with respect to news item captioned- Rs 50-bn scam: Sterling Biotech director Nitin Sandesara held in DubaiIn this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any informati

The Exchange had sought clarification from the Company with respect to news item captioned- ED charge sheet against Sterlite Biotech director. The response from the Company is attached.

The Exchange has sought clarification from the Company with respect to news item captioned- ED charge sheet against Sterlite Biotech director In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been

The Exchange had sought clarification from the Company with respect to news dated 16-Jul-2018. The response from the Company is attached.

The Exchange has sought clarification from the Company with respect to attached news item. In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of

The Exchange has sought clarification from the Company with respect to news item captioned- "Bank fraud - ED attaches Rs 4,701 cr assets of Gujarat pharma firm" In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any informatio

The Exchange has sought clarification from the Company with respect to news item captioned- "3 cos linked to bank fraud, bad debts face SFIO probe" In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has no

The Exchange has sought clarification from the Company with respect to news item captioned- "Andhra Bank moves NCLT against Sterling" In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announc

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "ED charges bank former director in Rs.5,000cr scam involving Sterling Biotech Ltd (SBL) of the Sandesara Group of companies". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "JSW Infra-Srei to buy Sterling Port in Dahej". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sterling Biotech Limited has submitted their response.

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "JSW Infra-Srei to buy Sterling Port in Dahej". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "Lenders plan to bring strategic investor in Sterling Port". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sterling Biotech Limited has submitted their response.

Significant increase in price has been observed in Sterling Biotech Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sterling Biotech Limited has submitted their response.

Significant increase in price has been observed in Sterling Biotech Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

The Exchange had sought clarification from the Company with respect to news item captioned "Rs 5k-cr loan default case: ED raids 7 Delhi locations of Sterling Biotech". In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any in

The Exchange has sought clarification from the Company with respect to news item captioned ��Rs 5k-cr loan default case: ED raids 7 Delhi locations of Sterling Biotech��. In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "Lenders plan to bring strategic investor in Sterling Port". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "CBI registers FIR against Sterling Biotech". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sterling Biotech Limited has submitted their response.

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "CBI registers FIR against Sterling Biotech". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

The Exchange had sought clarification from the Company with respect to news item captioned "CBI arrested Chetan Sandesara (Joint MD of Sterling Biotech) from Mumbai Airport in connection with Sandesara Group's Hawala scam." The response from the Company is attached.

The Exchange has sought clarification from the Company with respect to news item captioned "CBI arrested Chetan Sandesara (Joint MD of Sterling Biotech) from Mumbai Airport in connection with Sandesara Group's Hawala scam." In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this articl

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "CBI files FIR against Sterling Biotech; FIR files after suspicious transaction evidence allegedly found Fm Promoters residence". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sterling Biotech Limited has submitted their response.

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned "CBI files FIR against Sterling Biotech; FIR files after suspicious transaction evidence allegedly found Fm Promoters residence". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned ''High court ordered RBI to investigate-Writ from High Court to Baroda's company on account of wrongful investment''. In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned ''High court ordered RBI to investigate-Writ from High Court to Baroda's company on account of wrongful investment''. In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this

Clarification of News : The press had reports that Sterling Biotech Limited has taken controlling stake in Narmada Gelatine, part of Dubai-based Jumbo group of companies. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Sterling Biotech Limited has vide its letter inter-alia stated, "We hereby deny the news matter relating to acquisition of Narmada Gelatin".